We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-2.93%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$997M
AUM Growth
-$54.7M
Cap. Flow
-$15.6M
Cap. Flow %
-1.57%
Top 10 Hldgs %
45%
Holding
55
New
1
Increased
23
Reduced
16
Closed
6

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$21.2M
2
BAX icon
Baxter International
BAX
+$14.3M
3
ABBV icon
AbbVie
ABBV
+$10.7M
4
MDT icon
Medtronic
MDT
+$6.66M
5
TPR icon
Tapestry
TPR
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 31.09%
2 Consumer Staples 19.88%
3 Industrials 17.14%
4 Healthcare 15.02%
5 Consumer Discretionary 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSS
26
DELISTED
Total System Services, Inc.
TSS
$18.7M 1.88%
412,227
+18,541
+5% +$844K
BXLT
27
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$14.6M 1.46%
+463,211
New +$16M
BAX icon
28
Baxter International
BAX
$13.9B
$14.1M 1.42%
429,381
-378,271
-47% -$14.3M
EXPD icon
29
Expeditors International
EXPD
$24B
$12.6M 1.27%
268,083
+52,110
+24% +$2.46M
MKC icon
30
McCormick & Company Non-Voting
MKC
$14.2B
$12.5M 1.25%
303,048
-884
-0.3% -$35.9K
ADP icon
31
Automatic Data Processing
ADP
$107B
$11.3M 1.13%
140,707
-7,986
-5% -$640K
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.19T
$8.23M 0.83%
257,940
+32,800
+15% +$1.01M
CL icon
33
Colgate-Palmolive
CL
$73.6B
$5.22M 0.52%
82,320
-13,169
-14% -$860K
TPR icon
34
Tapestry
TPR
$31.1B
$3.13M 0.31%
108,051
-203,396
-65% -$6.29M
PSA.PRS.CL
35
DELISTED
Public Storage
PSA.PRS.CL
$726K 0.07%
28,755
-2,165
-7% -$54.7K
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$423K 0.04%
7,145
NGG icon
37
National Grid
NGG
$81.1B
$395K 0.04%
5,877
INTC icon
38
Intel
INTC
$509B
$394K 0.04%
13,067
+137
+1% +$3.96K
ABBV icon
39
AbbVie
ABBV
$440B
$390K 0.04%
7,160
-164,556
-96% -$10.7M
PAYX icon
40
Paychex
PAYX
$42.8B
$388K 0.04%
8,140
-1,750
-18% -$81.6K
MO icon
41
Altria Group
MO
$107B
$321K 0.03%
5,900
MNR
42
DELISTED
Monmouth Real Estate Investment Corp
MNR
$306K 0.03%
31,360
-2,400
-7% -$23.2K
K
43
DELISTED
Kellanova
K
$301K 0.03%
4,819
DEO icon
44
Diageo
DEO
$52.2B
$294K 0.03%
2,730
PFE icon
45
Pfizer
PFE
$150B
$275K 0.03%
9,244
SCCO icon
46
Southern Copper
SCCO
$165B
$244K 0.02%
9,973
MMP
47
DELISTED
Magellan Midstream Partners, L.P.
MMP
$240K 0.02%
4,000
-500
-11% -$34.1K
SE
48
DELISTED
Spectra Energy Corp Wi
SE
$237K 0.02%
9,015
NVS icon
49
Novartis
NVS
$290B
$228K 0.02%
2,768
BRK.A icon
50
Berkshire Hathaway Class A
BRK.A
$1.09T
-1
Closed -$205K

Similar funds

Saratoga Research & Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Saratoga Research & Investment Management held 55 positions worth $997M, down 5.2% from $1.05B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Saratoga Research & Investment Management's Q3 2015 filing shows 1 new, 23 increased, 16 reduced and 6 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 463,211 shares worth $14.6M. The largest sale was Stryker, an estimated $21.2M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Consumer Staples and Industrials.

  • Saratoga Research & Investment Management's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 463,211 shares worth $14.6M.
  • Saratoga Research & Investment Management added most to Apple in Q3 2015, an estimated $4.4M increase.
  • Saratoga Research & Investment Management's biggest Q3 2015 reduction was Baxter International, cutting an estimated $14.3M.
  • Saratoga Research & Investment Management fully exited Stryker in Q3 2015, selling an estimated $21.2M.
  • Saratoga Research & Investment Management's ten largest holdings make up 45% of its $997M portfolio in Q3 2015.
  • Saratoga Research & Investment Management opened 1 new position and closed 6 in Q3 2015.
  • Saratoga Research & Investment Management's portfolio value fell 5.2% quarter-over-quarter to $997M.

Based on Saratoga Research & Investment Management's 13F filing for Q3 2015, filed 19 Oct 2015.